Comparative effectiveness and safety of triple therapy and non-triple therapy interventions for COPD: an overview of systematic reviews
Background: Some systematic reviews (SRs) on triple therapy (consisting of long-acting β 2 -agonist, long-acting muscarinic antagonist, and inhaled corticosteroid, LABA/LAMA/ICS) for chronic obstructive pulmonary disease (COPD) have reported conflicting results. As the number of syntheses increases,...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-06-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/17534666241259634 |